Drug intelligence / Profile preview

Qiwei Tangmaishu Capsules

Development stage
Unknown
Lead developer
Kunming Longjin Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Qiwei Tangmaishu Capsules is a Chinese patent medicine (CPM) developed and manufactured by Kunming Longjin Pharmaceutical. It is an oral botanical drug primarily indicated for the treatment of Type 2 diabetes mellitus, specifically for patients presenting with Qi and Yin deficiency syndromes. The formulation is designed to lower blood glucose levels, alleviate symptoms such as polydipsia (excessive thirst), polyuria, and fatigue, and potentially address diabetic vascular complications. In Traditional Chinese Medicine (TCM) theory, the product functions to supplement Qi, nourish Yin, clear heat, and promote the production of body fluids. The 'Qiwei' (seven flavors) in its name refers to its seven primary herbal ingredients: Astragalus membranaceus, Rehmannia glutinosa, Pueraria lobata, Ophiopogon japonicus, Schisandra chinensis, Salvia miltiorrhiza, and Poria cocos.

Brand names
Qiwei Tangmaishu Capsules
Other names
七味糖脉舒胶囊Qiwei Tangmaishu Jiaonang

Beyond the preview

Go deeper on Qiwei Tangmaishu Capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qiwei Tangmaishu Capsules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call